Xbrane Biopharma AB

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 170.52% vs 90.11% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 11.72% vs 51.15% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "46.80",
          "val2": "17.30",
          "chgp": "170.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.00",
          "val2": "-7.90",
          "chgp": "-51.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "2.20",
          "chgp": "4.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.30",
          "val2": "-12.80",
          "chgp": "11.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-314.60%",
          "val2": "-616.70%",
          "chgp": "30.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 2.90% vs -37.96% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 67.30% vs 56.12% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "152.40",
          "val2": "148.10",
          "chgp": "2.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-62.20",
          "val2": "-48.70",
          "chgp": "-27.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "16.40",
          "val2": "33.00",
          "chgp": "-50.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-46.20",
          "val2": "-141.30",
          "chgp": "67.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-473.50%",
          "val2": "-492.60%",
          "chgp": "1.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

46.80

17.30

170.52%

Operating Profit (PBDIT) excl Other Income

-12.00

-7.90

-51.90%

Interest

2.30

2.20

4.55%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-11.30

-12.80

11.72%

Operating Profit Margin (Excl OI)

-314.60%

-616.70%

30.21%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 170.52% vs 90.11% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 11.72% vs 51.15% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

152.40

148.10

2.90%

Operating Profit (PBDIT) excl Other Income

-62.20

-48.70

-27.72%

Interest

16.40

33.00

-50.30%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-46.20

-141.30

67.30%

Operating Profit Margin (Excl OI)

-473.50%

-492.60%

1.91%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 2.90% vs -37.96% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 67.30% vs 56.12% in Dec 2024

All Annual Results